{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-022913","form_type":"8-K","ticker":"COCH","cik":"0001840877","company_name":"Envoy Medical, Inc.","filed_at":"2025-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.222700+00:00","generated_at":"2026-05-24T22:43:13.298351+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Envoy Medical obtains $10M promissory note from largest shareholder Glen Taylor","bullets":["Initial $5M funded on March 11, 2025; up to $10M available in $2.5M tranches over 2 years.","8.0% interest rate, deferred and compounding for first 2 years; 5-year term matures March 6, 2030.","Commitment fee: 375,000 warrants per $2.5M tranche; initial 750,000 warrants at $1.35/share exercise price.","Funds will support Acclaim cochlear implant pivotal clinical trial and general operations.","Glen Taylor is board member and controlling stockholder; facility unsecured with no conversion feature."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-022913","json":"https://secwatch.observer/filing/0001213900-25-022913.json","markdown":"https://secwatch.observer/filing/0001213900-25-022913.md","text":"https://secwatch.observer/filing/0001213900-25-022913.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840877/000121390025022913/0001213900-25-022913-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840877/000121390025022913/ea0234061-8k_envoy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T22:43:13.298351+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}